Home Therapies Rheumatoid Arthritis

Rheumatoid Arthritis

in Malaysia

About - What is Rheumatoid Arthritis?

Rheumatoid arthritis is a systemic autoimmune disease. Due to genetics, hormones, or the environment, the immune system begins mistakenly attacking healthy cells in the joints, causing inflammation. This inflammation causes the tissues lining the joints to thicken as well as swelling and pain. Over time, the cartilage in the joints becomes damaged, loose, and unstable, thereby, reducing mobility and deformity.

 

Treatment Methods

wjMSCs Treat Rheumatoid Arthritis by

01Modulating the immune system,
02Encouraging existing cells to self-repair,
03Reducing inflammation,
04Preventing healthy cells from dying, and
05Transforming into bone and cartilage cells.

Interested?

Talk to Your Primary Doctor First

They're pros who can give you personalized advice and recommend the latest treatment options that suit your unique condition.

One Size Does Not Fit All

Our doctors decide how many wjMSCs, the transfusion method, and the rounds of treatment that you need based on your medical records. So, be sure to send them to your patient liaison.

What Makes Us Different?

Premium grade passage 2 wjMSCs

Our premium grade passage 2 wjMSCs are ethically derived from the umbilical cord tissues of healthy human babies that have been delivered after 37 weeks of gestation.

cGMP & ISO 9001 certified

Our laboratory is not only current goods & manufacturing practices (cGMP) certified, but ISO 9001 certified as well, both of which are internationally recognised standards for quality management systems (QMS).

Crafters of high-quality products

Our bio-safety level (BSL) 2 laboratory adheres to international standard operating procedures to ensure cleanliness and sterility as well as the safety of the environment.

Patient journey for international patients

Enquire now

The Patient Liaison that you are assigned will require your medical information. To streamline the process, either send your existing medical records to your Patient Liaison or get a medical test done in your country of residence and send it to your Patient Liaison.

Planning your treatment

Your Patient Liaison will send your medical reports to our doctors, who will tailor a personalised treatment plan for you or request that you get more medical tests done in your country of residence and send it to your Patient Liaison.

Ready to begin?

Once you've agreed to the treatment plan, let your Patient Liaison know when you'd like to start your treatment. They'll coordinate with our doctors and book a treatment slot for you.

Secure your spot

Let your Patient Liaison know how many people will be accompanying you to Malaysia and if you have any special requirements, such as ambulance or wheelchair assistance. You'll need to pay a deposit depending on the duration of your treatment, number of travellers, and special needs so that your Patient Liaison may make appropriate hotel bookings and transport arrangements.

Visas made easy

Visit the Immigration Department of Malaysia's website to check if you need a visa to enter the country. You may apply for an electronic visa (eVisa) here. Let your Patient Liaison know if you require an Invitation Letter and they'll send you one.

Book your flight tickets

When booking your flight tickets, it's recommended to arrive two days before your treatment date and to depart the day after your treatment ends.

Malaysia Digital Arrival Card (MDAC) registration

Two days before your arrival in Malaysia, go to this link to register yourself and all other travellers.

Arrival & airport transfer

Your Patient Liaison will organise your airport transfer to the hotel and send you your driver's contact details via email. Log in to "Airport WiFi" to check your email once you've landed at KLIA and contact your driver.

Check-in & pay for treatment

Your Patient Liaison will meet you at the hotel and help you check-in. You will be required to pay the remainder of your treatment fee in order for the laboratory to begin preparing the products for your treatment, which will be two days later. We accept cash, online funds transfers, PayPal, and credit / debit cards (Visa, MasterCard, American Express, JCB, Union Pay).

Let the healing begin

Your Patient Liaison will arrange transportation to and from the treatment facility on the treatment date and walk you through the registration and discharge processes.

Show more

Research Findings

Multiple universities and institutions worldwide have examined the efficacy of using wjMSCs to treat rheumatoid arthritis and reported promising outcomes.

323 Hospital of Chinese People's Liberation Army, China
Improved American College of Rheumatology criteria, 28-joint disease activity, and the health assessment questionnaire scores; decreased tumour necrosis factor-alpha and interleukin-6 levels; and increased CD4(+)CD25(+)Foxp3(+) regulatory T cell levels.
Nanjing University Medical School, China
Significantly healed recurrent ulcers in rheumatoid arthritis patient within 3 months.
Hospital Universitario de La Princesa, Spain
Significantly decreased American College of Rheumatology scores.
Nanjing University Medical School, China
Decreased erythrocyte sedimentation rate, 28-joint disease activity score, pain visual analog scale score, and European League Against Rheumatism classification score.
Iranian Academic Center for Education, Culture and Research, Iran
Superior findings according to the Western Ontario and McMaster Universities Arthritis index, visual analogue scale, time to jelling, pain-free walking distance, methotrexate and prednisolone use.
Mashhad University of Medical Sciences, Iran
Significantly improved 28-joint disease activity, visual analogue scale scores, and regulatory T cell levels; and decreased T helper 17 cell and interleukin-17A levels.
986 Hospital of People’s Liberation Army Air Force, China
Decreased health assessment questionnaire and 28-joint disease activity scores, and erythrocyte sedimentation rate, C-reactive protein, and rheumatoid factor levels, all of which remained decreased throughout the follow-up period (3 years).
Boramae Medical Center, South Korea
Decreased 28-joint disease activity score, erythrocyte sedimentation rate, and interleukin-1β, interleukin-6, interleukin-8, and tumour necrosis factor-alpha levels.

Hear from Our Patients

More than 200 people have chosen Cyrona, why not you?
Learn more about our

Rheumatoid Arthritis

Therapy Programme
Captcha

Download our complimentary eBook!